Generare

Super article du Le Monde sur les travaux de Vincent, à l’INSERM et chez Generare ! Les métabolites secondaires microbiens découverts par Generare promettent des avancées majeures : traitements contre le cancer, immunosuppresseurs, herbicides naturels… et surtout, de nouveaux antibiotiques. Le lien vers l'article est en commentaire !

[FR below] moka.care, Exotec, Spore.Bio, Yuka, Selency, Fairmat, NeoCarbon, Theremia… and now Generare! 👊 We are very proud to join the RAISE Sherpas community. 🩵 RAISE Sherpas is a 100% free accelerator that provides funding and operational support to founders & C-Levels of startups driving socio-environmental transitions.🌿 They are also the team behind Phiture, the first 100% philanthropic tech fund that invests in startups' equity to donate all returns to charities. Thank you, Sherpas! --- moka.care, Exotec, Spore.Bio, Yuka, Selency, Fairmat, NeoCarbon, Theremia… et maintenant Generare! 👊 Nous sommes très fiers de rejoindre la communauté RAISE Sherpas.  🩵 RAISE Sherpas est un accélérateur 100% gratuit, qui apporte du financement et une aide opérationnelle aux founders & C-Levels de startups au service de la transition socio environnementale.🌿 C’est aussi l’équipe à l’initiative de Phiture, le 1er fonds tech 100% philanthropique qui investit au capital de startups pour reverser l’intégralité des gains à des association. Merci les Sherpas ! cc RAISE Anne Sophie GERVAIS Jerome Sussfeld Eugénie Cuny Louise Colin Laure Gutierrez

We are looking for a passionate microbiology intern to join the team early 2025! Link to the offer : https://lnkd.in/gedZ2quc Feel free to share if you know anyone 🙏

𝗦𝗮𝗺𝗽𝗹𝗲 microbes from the environment 𝗥𝗲𝘃𝗲𝗮𝗹 bioactive molecules at unprecedented speed and scale 𝗛𝗮𝗿𝗻𝗲𝘀𝘀 their potential for medicine and beyond More info: https://generare.bio/ Open positions: https://shorturl.at/nuTsh Credits: Units; Roman Weil; Tom Formont

The news is out! We’re thrilled to announce Generare has raised €5 million in Seed funding to take our drug discovery platform to the next level. Natural products hiding in bacteria are our best shot at finding the next generation of medicines – they’ve led to 500+ drugs already, and are 100x more likely than plants and chemicals to get approved. Yet finding them remains a significant global challenge. At Generare, we’re building a platform that is not only reopening this critical avenue of drug discovery, but can do so at scale; leveraging decades of research from our award-winning team. We’ve already identified 100+ previously unknown molecules (and counting); we’ve signed our first pilot with AUROBAC THERAPEUTICS; and been recognised by a number of industry bodies over the past year alone.  Today’s announcement of our Seed funding is the icing on the cake 🎂   Not only because it validates our mission and ambition, but because our new investors – Teampact.ventures, Galion.exe, VIVES Partners, SynBioVen, Saras Capital, Better Angle – bring a wealth of expertise that will now help us take this mission forward. Thanks to Natasha Lomas for covering our journey on TechCrunch, and to all of our team and partners that have been a part of this journey so far! We’re excited to take things to the next level in the weeks, months and years to come. Read the full announcement here : https://lnkd.in/exxfpFiA #biotech #innovation #drugdiscovery #naturalproducts

I am thrilled to share a new milestone in Generare's journey! We have closed a €5M funding round, led by Teampact.ventures, Galion.exe, and VIVES Partners, to scale up our platform for discovering natural molecules from microorganisms. Nature holds treasures in the form of natural molecules, selected by evolution over millions of years. Thanks to Generare's technology, we systematically explore this wealth to transform the way we develop the medicines of tomorrow. I am proud and excited to be on this adventure with Vincent Libis, Baudoin Delépine, Héloïse G., Oriane Monet, Nadège Guinot, Baptiste F., Bismarck Olympio, Humbeline Paupelin (Vaucelle), GUIDO RODRIGO, Hugo Boutonnet, Anne-Camille Renaudeau, Charlotte Thiola, and Grace K. For the past two years, we have been working together to scale up this approach, inspired by Vincent's brilliant research. A big thank you to everyone who is a part of this adventure! Thanks Natasha Lomas of TechCrunch for covering our journey! https://tcrn.ch/3ZS9nr1

Très fier de mon associé Vincent Libis, lauréat du Prix des innovateurs de la Région Ile de France, et des travaux menés en collaboration par les équipes de l'INSERM et Generare pour accélérer la découverte de nouveaux médicaments issus de microorganismes, et notamment de nouveaux antibiotiques dont nous manquons cruellement. #antibioresistance #startup #iledefrance PS : Bravo aux équipes de la Région et Marie Morel pour la vidéo qui est très chouette !

Generare is proud to be part of this year's selection of amazing frontier science startups of the i-lab Grant from Gouvernement, ADEME and Bpifrance Congrats to Nūmi, Orakl Oncology, Linium Biochemicals and all the other amazing projects who were awarded.

Join Generare, where synthetic biology meets computational methods to harness the ingenuity of nature. Be part of our mission to create a discovery engine for Natural Products – first-in-class drugs encoded in the DNA of microbes from the soil.